Ontario Maternal Serum Screening Program: practices, knowledge and opinions of health care providers

作者: J. Kilthei , J. A. Permaul-Woods , S. Arbitman , B. Fallis , C. A. Woodward

DOI:

关键词:

摘要: OBJECTIVE: To determine the practices, knowledge and opinions of health care providers regarding a prenatal genetic screening program in Ontario. DESIGN: Cross-sectional self-reported survey. SETTING: PARTICIPANTS: Random sample 2000 family physicians, all 565 obstetricians 62 registered midwives province. Among subjects who were eligible (those providing antenatal or attending births) response rates 91% (778/851), 76% (273/359) 78% (46/59) respectively. MAIN OUTCOME MEASURES: Which patients offered maternal serum (MSS), how results being communicated, test9s sensitivity, likes dislikes about MSS recommendations program. RESULTS: Most (97%) respondents stated that they offering to pregnant women their practices; 88% it routinely (87% 90% 100% midwives). (92%) communicate positive personally as soon are received; 23% did so for negative results. The correctly identified initial rate but underestimated false-positive rate. About one-third not respond these questions. Of those gave feedback on program, 50% recommended be changed, 29% suggested 22% scrapped. CONCLUSIONS: Participation Ontario Maternal Serum Screening Program by has been good, although is far from ideal. Many have reservations In light concerns raised high anxiety such generate women, there need more education better understanding women9s experiences with screening.

参考文章(14)
S. Harris, T. Lam, J. Dooley, N. Beardy, M. Dillon, J. Gordon, Maternal serum screening in the Sioux Lookout Zone. Complicated test for an unspecified need. Canadian Family Physician. ,vol. 40, pp. 1766- ,(1994)
David A. Luthy, Arthur M. Zebelman, Edith Y. Cheng, Michelle A. Williams, Durlin E. Hickok, Robert E. Lieppman, A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Obstetrics & Gynecology. ,vol. 81, pp. 72- 77 ,(1993)
M. K. Evensen, A. E. Borgiel, R. A. Spasoff, J. M. McCoy, J. I. Williams, P. J. MacDonald, C. T. Lamont, E. V. Dunn, M. J. Bass, Quality of care in family practice: does residency training make a difference? Canadian Medical Association Journal. ,vol. 140, pp. 1035- 1043 ,(1989)
Carroll Jc, Maternal serum screening. Canadian Family Physician. ,vol. 40, pp. 1756- 1764 ,(1994)
Jerome Yankowitz, Donald M. Howser, John W. Ely, Differences in practice patterns between obstetricians and family physicians: use of serum screening. American Journal of Obstetrics and Gynecology. ,vol. 174, pp. 1361- 1365 ,(1996) , 10.1016/S0002-9378(96)70685-3
Leonard H. Kellner, Robert R. Weiss, Zeev Weiner, Marsha Neuer, Gregory M. Martin, Harold Schulman, Stanley Lipper, The advantages of using triple-marker screening for chromosomal abnormalities American Journal of Obstetrics and Gynecology. ,vol. 172, pp. 831- 836 ,(1995) , 10.1016/0002-9378(95)90007-1
James E. Haddow, Glenn E. Palomaki, George J. Knight, Josephine Williams, Andrea Pulkkinen, Jacob A. Canick, Devereux N. Saller, Gail Barsel Bowers, Prenatal screening for Down's syndrome with use of maternal serum markers. The New England Journal of Medicine. ,vol. 327, pp. 588- 593 ,(1992) , 10.1056/NEJM199208273270902
Glenn E. Palomaki, George J. Knight, James E. Haddow, Jacob A. Canick, Devereux N. Saller, Diane S. Panizza, Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha‐fetoprotein, unconjugated oestriol, and human chorionic gonadotropin Prenatal Diagnosis. ,vol. 12, pp. 925- 930 ,(1992) , 10.1002/PD.1970121112
N. J. Wald, A. Kennard, J. W. Densem, H. S. Cuckle, T. Chard, L. Butler, Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ. ,vol. 305, pp. 391- 394 ,(1992) , 10.1136/BMJ.305.6850.391